Inhibitory action of insulin-sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guinea-pig

British Journal of Pharmacology

Volumn 123, Issue 4, 1998, Pages 675-682

  Nakamura, Yoshito ^a   Ohya, Yusuke ^a   Onaka, Uran ^a   Fujii, Koji ^a   Abe, Isao ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Bezafibrate; Calcium channel; Electrophysiology; Insulin resistance; Metformin; Pioglitazone; Troglitazone; Vascular smooth muscle

Indexed keywords

ANTIDIABETIC AGENT; CALCIUM CHANNEL;

ANIMAL; ARTERY; ARTICLE; CELL MEMBRANE POTENTIAL; CHANNEL GATING; CYTOLOGY; DRUG EFFECT; FEMALE; GUINEA PIG; IN VITRO STUDY; INSULIN RESISTANCE; PATCH CLAMP; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIES; CALCIUM CHANNELS; FEMALE; GUINEA PIGS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; ION CHANNEL GATING; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES;

EID: 0031990410     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701669     Document Type: Article

References (31)

1. BEAN, B.P. (1984). Nitrendipine block of cardiac calcium channels: High-affinity binding to the inactivated state. Proc. Natl. Acad. Sci. U.S.A., 81, 6388 - 6392.
2. BUCHANAN, T.A., MEEHAN, W.P., JENG, Y.Y., YANG, D., CHAN, T.M., NADLER, J.L., SCOTT, S., RUDE, R.K. & HSUEH, W.A. (1995). Blood pressure lowering by pioglitazone evidence for a direct vascular effect. J. Clin. Invest., 96, 354 - 60.
3. CIARALDI, T.P., GILMORE, A., OLEFSKY, J.M., GOLDBERG, M. & HEIDENREICH, K.A. (1990). In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism, 39, 1056 - 1062.
4. FERRANNINI, E., HAFFINER, S.M. & STERN, M.P. (1990). Hypertension: an insulin-resistance state. J. Cardiovasc. Pharmacol., 15 (Suppl 5). S18 - S25.
5. FERRANNINI, E., SMITH, J.D., COBELLI, C., TOFFOLO, G., PILO, A. & DEFRONZO, R.A. (1985). Effect of insulin on the distribution and disposition of glucose in man. J. Clin. Invest., 76, 357 - 364.
6. FLEIG, W.E., NOETHER-FLEIG, G., FUSSGAENGER, R. & DITSCHNEIT, H. (1984). Modulation by insulin-dependent glycogenesis. but not of insulin binding, in cultured rat hepatocytes evidence for postreceptor mechanism of action. Diabetes, 33, 285 - 290.
7. FUJIWARA, T., YOSHIOKA, S., YOSHIOKA, T. HORIOSHI, H. (1988). Characterization of new oral antidiabetic agent CS-045-study in KK and ob ob mice and Zuker fatty rats. Diabetes, 37, 1549 - 1558.
8. GIUGLIANO, D., QUATRARO, A., CONSOLI, G., MINEI, A., CERIELLO, A., DEROSA, N. & D'ONOFRIO, F. (1993). Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur. J. Clin. Pharmacol., 44, 107 - 112.
9. HIRAGA, K. (1997). The clinical phase I study of AD-4833 Single-dose study and repeated-dose study (in Japanese). Jpn. J. Clin. Exp. Med., 74, 1184 - 1201.
10. HOFFMAN, C., LORENTZ, K. & COLA, J.R. (1991). Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone. Endocrinology, 129, 1915 - 1925.
11. HORN, A. & MARTY, A. (1988). Muscarinic activation of ionic-currents measured by a new whole-cell recording method. J. Gen. Physiol., 92, 145 - 159.
12. KAPLAN, N.M. (1992). Effects of antihypertensive therapy on insulin resistance. Hypertension. 19 (Suppl 1), I 116 - I 118.
13. KAUFMAN, L.N., PETERSON, M.M. & DEGRANGE, L.M. (1995). Pioglitazone attenuates diet-induced hypertension in rats. Metabolism, 44, 1105 - 1109.
14. KEMNITZ, J.W., ELSON, D.F., ROEKER, E.B., BAUM, S.T., BERGMAN, R.N. & MEGLASSON, M.D. (1994). Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obsese, insulin-resistant rhesus monkeys. Diabetes, 43, 204 - 211.
15. KOTCHEN, T.A. (1996). Attenuation of hypertension by insulin-sensitizing agents. Hypertension, 28, 219 - 222.
16. LANDIN, K., TENGBORN, L. & SMITH, U. (1994). Metformin and metoprolol CR treatment in non-obese men. J. Intern. Med., 235, 335 - 341.
17. LANDSBERG, L. (1996). Insulin sensitivity in the pathogenesis of hypertension and hypertensive complication. Clin. Exp. Hypertens., 18, 337 -146.
18. LEE, K.S. & TSIEN, R.W. (1983). Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature, 302, 790 - 794.
19. LEE, M.K., MILES, P.D., KHOURSHEED, M., GAO, K.M., MOOSSA, A.R. & OLEFSKY, J.M. (1994). Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes, 43, 1435 - 1439.
20. OGIHARA, T., RAKUGI, H., IKEGAMI, H., MIKAMI, H. & MASUNO, K. (1995). Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am. J. Hypertens., 8, 316 - 320.
21. 2+ channels in resistance arteries from spontaneously hypertensive rats. Circ. Res., 73, 1090 - 1099.
22. OHYA, Y., ADACHI, N., ABE, I. & FUJISHIMA, M. (1997). Effects of CP-060S on membrane channels in vascular smooth muscle cells from guinea-pig. Eur. J. Pharmacol. (in press).
23. OHYA, Y. & SPERELAKIS, N. (1989). ATP regulation of the slow calcium channels in vascular smooth muscle cells of guinea pig mesenteric artery. Circ. Res., 64, 145 - 154.
24. PASSA, P. (1993). Insulin resistance and hypertension. Clin. Exp. Hypertens., 15, 1047 - 1059.
25. PERSHADSINGH, H.A., SZOLLOSI, J. BENSON, S., HYUN, W.C., FEUERSTEIN, B.G. & KURTZ, T.W. (1993). Effects of ciglitazone on blood pressure and intracellular calcium metabolism. Hypertension, 21, 1020 - 1023.
26. 1-selective adrenoceptor antagonist, on voltage-dependent calcium channels in guinea-pig artery and vein. Br. J. Pharmacol., 115, 198 - 202.
27. SHIBATA, M., NII, S., KOBAYASHI, M., IZUMI, T., SASAHARA, K. & YAMAGUCHI, K. (1993). Phase I study of a new hypoglycemic agent CS-045 in healthy volunteers safety and pharmacokinetics in reported administration (in Japanese). Rinsho Iyaku, 9, 1519 - 1537.
28. 2+ channels in the smooth muscle cell membrane of rabbit small intestine. Pflügers Arch., 408, 552 - 557.
29. YOSHIOKA, S., NISHINO, H., SHIRAKI, T., IKEDA, K., KOIKE, H., OKUNO, A., WADA, M., FUJIWARA, T. & HORIKOSHI, H. (1993). Antihypertensive effects of CS-045 treatment in obese Zucker rats. Metabolism, 42, 75 - 80.
30. ZHANG, F., SOWERS, J.R., RAM, J.L., STANDLEY, P.R. & PEULER, J.D. (1994). Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension, 24, 170 - 175.
31. 2+ influx in vascular smooth muscle cells of normotensive and spontaneous hypertensive rats. Clin. Sci., 85, 425 - 429.